rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2000-8-30
|
pubmed:abstractText |
Fifty patients enrolled in clinical trials with Immucothel((R)) were reevaluated for their disease-free intervals.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0302-2838
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2000 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
37 Suppl 3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
50-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10828688-Adjuvants, Immunologic,
pubmed-meshheading:10828688-Aged,
pubmed-meshheading:10828688-Aged, 80 and over,
pubmed-meshheading:10828688-Antibiotics, Antineoplastic,
pubmed-meshheading:10828688-BCG Vaccine,
pubmed-meshheading:10828688-Female,
pubmed-meshheading:10828688-Humans,
pubmed-meshheading:10828688-Male,
pubmed-meshheading:10828688-Middle Aged,
pubmed-meshheading:10828688-Mitomycin,
pubmed-meshheading:10828688-Neoplasm Recurrence, Local,
pubmed-meshheading:10828688-Urinary Bladder Neoplasms
|
pubmed:year |
2000
|
pubmed:articleTitle |
Efficacy of prophylactic Immucothel in patients pretreated with conventional drugs to prevent recurrence of superficial bladder carcinoma.
|
pubmed:affiliation |
Department of Urology, General Academic Hospital, Celle, Germany. Christine_Echarti@biosyn.de
|
pubmed:publicationType |
Journal Article,
Comparative Study
|